Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
Lloyd Inc is recalling 19,039 bottles of Levothroid 75 mcg tablets because the drug tested below the required potency level.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) when no specific hospitalizations or severe injuries are reported in the source text, fitting the criteria for low-risk contamination or minor labeling/potency issues without immediate severe harm.
Plain-English summary
Lloyd Inc is recalling 19,039 bottles of Levothroid (levothyroxine sodium tablets, USP), 75 mcg, 100-count bottles. The product is identified by NDC 0456-1322-01 and Lot No. 1092045. The recall was initiated because the drug was found to be subpotent, meaning it had a low assay at the 6-month test interval.
The affected product was manufactured for Forest Pharmaceuticals, Inc., a subsidiary of Forest Laboratories, Inc., in St. Louis, MO, by Lloyd Pharmaceutical in Shenandoah, Iowa. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this specific lot of Levothroid should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The product was distributed nationwide.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601
- Manufacturer
- Lloyd Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 19,039
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- LOT NO.1092045
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Lloyd Inc
See all →- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02